Kymera Therapeutics (NasdaqGM:KYMR) Update / Briefing Transcript

Kymera Therapeutics (NasdaqGM:KYMR) Update / Briefing December 08, 2025 08:00 AM ET Company ParticipantsJustine Koenigsberg - Head of Investor RelationsGeoff Meacham - Global Head of HealthcareMayank Mamtani - Group Head of Healthcare ResearchJared Gollob - Chief Medical OfficerBruce Jacobs - CFONello Mainolfi - Founder, President, and CEOConference Call ParticipantsAndrea Newkirk - Equity AnalystJeet Mukherjee - VP and Biotechnology AnalystBrian Cheng - Senior Biotech AnalystSudan Loganathan - Biotechnolog ...